Morgan Stanley (MS) is Attracting Investor Attention: Here is What You Should Know

12.11.24 15:00 Uhr

Werte in diesem Artikel
Aktien

117,02 EUR -3,88 EUR -3,21%

Indizes

PKT PKT

16.792,5 PKT -32,7 PKT -0,19%

2.887,6 PKT 3,1 PKT 0,11%

5.867,1 PKT -5,1 PKT -0,09%

Morgan Stanley (MS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this investment bank have returned +18.9%, compared to the Zacks S&P 500 composite's +3.3% change. During this period, the Zacks Financial - Investment Bank industry, which Morgan Stanley falls in, has gained 12.5%. The key question now is: What could be the stock's future direction?Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.For the current quarter, Morgan Stanley is expected to post earnings of $1.54 per share, indicating a change of +36.3% from the year-ago quarter. The Zacks Consensus Estimate has changed +3.6% over the last 30 days.For the current fiscal year, the consensus earnings estimate of $7.32 points to a change of +34.1% from the prior year. Over the last 30 days, this estimate has changed +5.5%.For the next fiscal year, the consensus earnings estimate of $7.88 indicates a change of +7.6% from what Morgan Stanley is expected to report a year ago. Over the past month, the estimate has changed +4%.Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Morgan Stanley is rated Zacks Rank #2 (Buy).The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:12 Month EPSRevenue Growth ForecastEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.For Morgan Stanley, the consensus sales estimate for the current quarter of $14.53 billion indicates a year-over-year change of +12.7%. For the current and next fiscal years, $60.05 billion and $62.89 billion estimates indicate +10.9% and +4.7% changes, respectively.Last Reported Results and Surprise HistoryMorgan Stanley reported revenues of $15.38 billion in the last reported quarter, representing a year-over-year change of +15.9%. EPS of $1.88 for the same period compares with $1.38 a year ago.Compared to the Zacks Consensus Estimate of $14.27 billion, the reported revenues represent a surprise of +7.77%. The EPS surprise was +19.75%.The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates each time over this period.ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.Morgan Stanley is graded D on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Morgan Stanley. However, its Zacks Rank #2 does suggest that it may outperform the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Morgan Stanley (MS): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

Ausgewählte Hebelprodukte auf CGI Group

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CGI Group

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Morgan Stanley

Analysen zu Morgan Stanley

DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
20.04.2021Morgan Stanley kaufenCredit Suisse Group
DatumRatingAnalyst
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
20.04.2021Morgan Stanley kaufenCredit Suisse Group
15.10.2020Morgan Stanley OutperformRBC Capital Markets
05.10.2020Morgan Stanley OutperformRBC Capital Markets
DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
02.04.2020Morgan Stanley neutralDeutsche Bank AG
21.01.2020Morgan Stanley NeutralCitigroup Corp.
04.04.2019Morgan Stanley HoldHSBC
DatumRatingAnalyst
20.01.2016Morgan Stanley SellSociété Générale Group S.A. (SG)
25.07.2011Morgan Stanley underperformRBC Capital Markets
02.10.2009Morgan Stanley underperformCalyon Securities Inc.
31.08.2005Morgan Stanley underweightPrudential Financial
28.07.2005Morgan Stanley underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Morgan Stanley nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"